Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Equity

Amneal Pharmaceuticals Inc Total Equity Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Equity from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Total Equity for the quarter ending December 12, 2018 was $896m a 141.15% increase of 1,265m year over year
  • Amneal Pharmaceuticals Inc Total Equity for the last 12 months ending December 12, 2018 was $896m a 141.15% increase of 1,265m year over year
  • Amneal Pharmaceuticals Inc Annual Total Equity for 2018 was $896m a 141.90% increase of 1,272m from 2017
  • Amneal Pharmaceuticals Inc Annual Total Equity for 2017 was $-376m a 53.15% decrease of -200m from 2016
  • Amneal Pharmaceuticals Inc Annual Total Equity for 2016 was $-176m a -6.21% increase of 11m from 2015
Other Balance Sheet Metrics:
  • Amneal Pharmaceuticals Inc Total Assets for the quarter ending December 12, 2018 was $4,353m a 68.78% increase of 2,994m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
View Chart On Koyfin

Quarterly AMRX Total Equity Data

12/2018$896m
09/2018$915m
06/2018$951m
03/2018$-369m
12/2017$-376m
09/2017$-426m
03/2017$-176m
12/2016$-176m

Annual AMRX Total Equity Data

2018$896m
2017$-376m
2016$-176m
2015$-187m